Single Session Class to Reduce Opioid Use in Chronic Pain

Not Recruiting

Trial ID: NCT03950791


Prescription opioids are one of the most commonly used treatments for chronic pain, despite limited evidence of their efficacy and high morbidity and mortality risks. The study aims to determine the efficacy of a targeted single-session psychology class in reducing opioid use among patients with chronic pain. The information gained from this study has the potential to identify patients who achieve a meaningful reduction in opioid use and inform opioid reduction strategies.

Official Title

Single Session Pain Catastrophizing Class: Efficacy & Mechanisms for Reducing Opioid Use Among Chronic Pain Patients

Stanford Investigator(s)

Maisa Ziadni, PhD

Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine


Inclusion Criteria:

* 18-80 years of age
* Diagnosis of chronic non-cancer pain (\> 3 months in duration)
* Currently using prescription opioids ≥ 20mg morphine equivalent daily dose (MEDD) for ≥ 3 months;
* Ability and willingness to complete study procedures.

Exclusion Criteria:

* Open litigation regarding a medical condition
* Inability to provide informed consent and complete study procedures
* Active suicidality.


behavioral: Pain Catastrophizing Class

behavioral: Health Education

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Maisa Ziadni